Caligan Partners LP - Nov 19, 2025 SCHEDULE 13D/A Report for Anika Therapeutics, Inc. Common Stock, par value $0.01 per share (ANIK)

Filing Manager
Caligan Partners LP
Reporting Manager
Caligan Partners LP
Security
Anika Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol
ANIK
Shares outstanding
14.4M shares
Disclosed Ownership
1.44M shares
Ownership
9.95%
Form type
SCHEDULE 13D/A
Date filed
11/21/2025, 09:21 AM
Date of event
Nov 19, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Caligan Partners LP 9.95% 1.44M 0 1.44M /s/ David Johnson David Johnson, Managing Partner 0001727492
David Johnson 9.95% 1.44M 0 1.44M /s/ David Johnson David Johnson, individually 0001785557